Authors
Latest:
Tools and Resources for the Management of MSDrs Jeffrey Dunn and Regina Berkovich review available tools and resources for the care of patients with multiple sclerosis, focusing on specific symptoms.
Latest:
Tapping Into the Potential of Cell and Gene TherapyAdvancements in gene therapy approaches have opened the door for a glimpse into the future of care for a number of diseases.
Latest:
Educating the Public on the Common Risk Factors for Stroke Awareness: Brandon Giglio, MDThe director of vascular neurology at NYU Langone Hospital in Brooklyn discussed the high prevalence of common risk factors for stroke, emphasizing the importance of early detection and management for prevention. [WATCH TIME: 4 minutes]
Latest:
New Horizons in Multiple SclerosisExperts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.
Latest:
Role of Advocacy Organizations in Seizure Action Plans, Seizure EducationA roundtable discussion featuring Scott Perry, MD, Orrin Devinsky, MD, and Tracy Salazar, PhD, details how advocacy organizations can help guide patients with epilepsy and their caregivers with a seizure action plan.
Latest:
Resources for Sleep DisordersDrs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson share resources for the treatment of sleep disorders.
Latest:
Key Points for the Management of Multiple SclerosisStephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, provide key takeaways for the treatment of patients with multiple sclerosis.
Latest:
Expanding the Boundaries of Neurosurgical Care: Recent Advances Give Patients New HopeInnovative neurosurgical advances in imaging/mapping, robotic assistance, and extended reality enable surgeons to more precisely and effectively treat neurological conditions such as brain tumor, epilepsy, Parkinson Disease, and stroke, giving patients new hope and a chance for more successful outcomes.
Latest:
CMSC Live: 2024 Annual Meeting Day 1Host Jeffrey Wilken, PhD, chats with Robert Naismith, MD; Jiwon Oh, MD, PhD; and Anthony Traboulsee, MD, about the first day of the 2024 CMSC Annual Meeting in Nashville, Tennessee.
Latest:
Reviewing Updated Epilepsy Guidelines to Prioritize Outpatient Focus and Patient-Centric Approach: Fred Lado, MD, PhDThe professor of neurology at the Zucker School of Medicine at Hofstra-Northwell talked about recently updated epilepsy care guidelines that shift the focus to outpatient care, incorporating broader aspects like care coordination, medication access, and patient-identified needs. [WATCH TIME: 5 minutes]
Latest:
The Intricate Relationship Between Biological Aging and Multiple Sclerosis: Yinan Zhang, MDThe assistant professor of neurology at The Ohio State University Wexner Medical Center talked about results from an ongoing study assessing biological aging in patients with multiple sclerosis using epigenetic clocks and p16INK4a. [WATCH TIME: 6 minutes]
Latest:
Advancements and Challenges in Genetic Treatments for Neuromuscular Diseases: John W. Day, MD, PhDAhead of the 2024 MDA Conference, the medical advisor and care center director at Muscular Dystrophy Association talked about the track sessions he will be cochairing at the meeting. [WATCH TIME: 5 minutes]
Latest:
Role of Advocacy Organizations in Creating Safe Spaces for Rare DisordersA panel of neurology experts detailed the importance that community leadership and creating a positive environment can do for patients with rare neurologic disorders [WATCH TIME: 5 minutes]
Latest:
How COViMS Registry Is Clarifying MS COVID-19 Risks: Amber Salter, MPH, PhDThe assistant professor of biostatistics at Washington University in St. Louis discussed what role the COViMS registry can play for the MS community at this stage in the pandemic.
Latest:
MS Biomarkers: Overview of Current and Emerging MarkersThis article reviews emerging MRI, OCT, CSF, and blood biomarkers, highlighting their potential roles in improving MS patient management and prognosis.
Latest:
Future of Treating Parkinson Disease Psychosis, Overcoming Challenges in Clinical Trials: Aaron Ritter, MDThe director of the Memory & Cognitive Disorders Clinic at Hoag Neuroscience Institute provided perspective on the difficulties with testing agents for Parkinson disease psychosis, and the future outlook of treating the symptom. [WATCH TIME: 4 minutes]
Latest:
Unravel the Mysteries of Multiple Sclerosis MimicsDespite the diagnosis of MS improving, misdiagnosis remains a challenge, pointing to the need for proper differential diagnosis and mimic identification.
Latest:
Digital Treatment Approach May Help Reduce Healthcare Burden for MS Fatigue: Federica Picariello, PhDThe postdoctoral researcher and health psychologist at King's College London spoke at ECTRIMS 2022 about the digital approach to treating fatigue in multiple sclerosis and the lack of available measurements. [WATCH TIME: 3 minutes]
Latest:
Understanding the Therapeutic Potential of Lomecel-B for Alzheimer Disease: Joshua Hare, MDThe co-founder and chief science officer at Longeveron provided commentary on the therapeutic potential of Lomecel-B, a living cell product in development for patients with Alzheimer disease. [WATCH TIME: 3 minutes]
Latest:
Examining Depression and Suicidality in Pediatric Patients With MS: Sarah C. Stoney, MSW, LSWThe social worker in the Pediatric Multiple Sclerosis Clinic at Children's Hospital of Philadelphia talked about depression and suicidality rates in pediatric patients with multiple sclerosis. [WATCH TIME: 5 minutes]
Latest:
Unseen Battles: Advocacy and Community in the Face of Myasthenia GravisAnaya, a young woman with myasthenia gravis, discusses her challenges and triumphs living with a rare disease. She shares her personal story of advocacy and community, finding strength in the disease's impact on her independence and identity.
Latest:
New Frontiers in the Prevention of Seizures, Gene Therapy in Epilepsy: William Gallentine, DOThe interim chief of pediatric neurology at Stanford Medicine Children’s Health discussed progress in preventing seizures among patients with epilepsy, the potential for gene-targeted therapies, and the importance of localizing where seizures are coming from. [WATCH TIME: 5 minutes]
Latest:
Bidirectionality of the Relaunched Myasthenia Gravis Patient Registry: Paul Strumph, MDThe lead of the Myasthenia Gravis Foundation of America Global Myasthenia Gravis Patient Registry spoke on 2 additional attributes of the patient registry. [WATCH TIME: 3 minutes]
Latest:
Multiple Sclerosis Care During a PandemicJoin Ahmed Obeidat, MD, PhD; Anne Cross, MD; and Gloria von Geldern, MD, for the third program in this series, where they offer insight from neurology specialists on applying lessons learned from the COVID-19 pandemic into clinical practice when managing patients with multiple sclerosis.
Latest:
Addressing the Greatest Needs in ALS: Calaneet Balas, MSc, MBAThe president and chief executive officer of The ALS Association provided insight on the most pressing needs for patients with ALS and the organization’s focus going forward. [WATCH TIME: 5 minutes]
Latest:
Raising Awareness to Improve Early Diagnosis and Treatment of Duchenne Muscular Dystrophy: Douglas Sproule, MD, MScThe chief medical officer at ML Bio Solutions, an affiliate of BridgeBio, talked about the importance of awareness for neuromuscular diseases such as Duchenne muscular dystrophy and why a timely diagnosis can make a profound difference in a patient’s life. [WATCH TIME: 3 minutes]
Latest:
Key Challenges and Future Directions of Targeting mTOR for Epileptic Disorders: Ghayda Mirzaa, MDThe principal investigator at Seattle Children’s Research Institute described some of the ongoing questions that remain with developing therapeutics that target mTOR signaling pathway in pediatric epilepsy conditions. [WATCH TIME: 3 minutes]
Latest:
Advances in Minimally Invasive Diagnostic Tests for Neurodegenerative Diseases: David Shprecher, DO, MSci, FAANThe director of movement disorders at the Banner Sun Health Research Institute talked about making strides in developing minimally invasive tests and imaging ligands for neurodegenerative diseases, such as Parkinson disease. [WATCH TIME: 2 minutes]
